# LV Endocardial Cardiac Resynchronisation Therapy

> **NCT02174289** · NA · UNKNOWN · sponsor: **Royal Brompton & Harefield NHS Foundation Trust** · enrollment: 32 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Targeted left ventricular endocardial lead placement

## Key facts

- **NCT ID:** NCT02174289
- **Lead sponsor:** Royal Brompton & Harefield NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2017-04
- **Final completion:** —
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2014-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02174289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02174289, "LV Endocardial Cardiac Resynchronisation Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02174289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*